3-(2-METHYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACIDHYDROCHLORIDE
- $110 - $795.8
- Product name: 3-(2-METHYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACIDHYDROCHLORIDE
- CAS: 1185293-51-9
- MF: C12H13ClN2O2
- MW: 252.7
- EINECS:
- MDL Number:MFCD09997628
- Synonyms:3-(2-METHYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACIDHYDROCHLORIDE;3-((2-Methyl-1H-imidazol-1-yl)methyl)benzoic acid hydrochloride
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
- TRC
Package
- 50mg
- 500MG
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0084781
- Product description3-(2-METHYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID HYDROCHLORIDE 95.00%
- Packaging500MG
- Price$795.8
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11338840
- Product description3-((2-Methyl-1H-imidazol-1-yl)methyl)benzoicacidhydrochloride 97%
- Packaging5g
- Price$627
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number026507
- Product description3-(2-Methyl-imidazol-1-ylmethyl)-benzoic acidhydrochloride
- Packaging500mg
- Price$118
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM323895
- Product description3-(2-Methyl-imidazol-1-ylmethyl)-benzoicAcidHydrochloride
- Packaging50mg
- Price$110
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0084781 | 3-(2-METHYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID HYDROCHLORIDE 95.00% | 500MG | $795.8 | 2021-12-16 | Buy |
Crysdot | CD11338840 | 3-((2-Methyl-1H-imidazol-1-yl)methyl)benzoicacidhydrochloride 97% | 5g | $627 | 2021-12-16 | Buy |
Matrix Scientific | 026507 | 3-(2-Methyl-imidazol-1-ylmethyl)-benzoic acidhydrochloride | 500mg | $118 | 2021-12-16 | Buy |
TRC | M323895 | 3-(2-Methyl-imidazol-1-ylmethyl)-benzoicAcidHydrochloride | 50mg | $110 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|